| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 913 | 2019 |
| Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. RJ Murray, MG Kurilla, JM Brooks, WA Thomas, M Rowe, E Kieff, ... The Journal of experimental medicine 176 (1), 157-168, 1992 | 632 | 1992 |
| The immunology of Epstein-Barr virus–induced disease GS Taylor, HM Long, JM Brooks, AB Rickinson, AD Hislop Annual review of immunology 33, 787-821, 2015 | 553 | 2015 |
| Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. SP Lee, RJ Tierney, WA Thomas, JM Brooks, AB Rickinson Journal of immunology (Baltimore, Md.: 1950) 158 (7), 3325-3334, 1997 | 262 | 1997 |
| CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1 SP Lee, JM Brooks, H Al-Jarrah, WA Thomas, TA Haigh, GS Taylor, ... The Journal of experimental medicine 199 (10), 1409-1420, 2004 | 197 | 2004 |
| T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of … PO de Campos-Lima, V Levitsky, J Brooks, SP Lee, LF Hu, AB Rickinson, ... The Journal of experimental medicine 179 (4), 1297-1305, 1994 | 182 | 1994 |
| CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines HM Long, TA Haigh, NH Gudgeon, AM Leen, CW Tsang, J Brooks, ... Journal of virology 79 (8), 4896-4907, 2005 | 180 | 2005 |
| Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. JM Brooks, RJ Murray, WA Thomas, MG Kurilla, AB Rickinson The Journal of experimental medicine 178 (3), 879-887, 1993 | 141 | 1993 |
| Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes JH Kessler, S Khan, U Seifert, S Le Gall, KM Chow, A Paschen, ... Nature immunology 12 (1), 45-53, 2011 | 137 | 2011 |
| T cell recognition of Epstein-Barr virus associated lymphomas. AB Rickinson, RJ Murray, J Brooks, H Griffin, DJ Moss, MG Masucci Cancer Surveys 13, 53-80, 1992 | 122 | 1992 |
| Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. RJ Murray, MG Kurilla, HM Griffin, JM Brooks, M Mackett, JR Arrand, ... Proceedings of the National Academy of Sciences 87 (8), 2906-2910, 1990 | 115 | 1990 |
| Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines VL Crotzer, RE Christian, JM Brooks, J Shabanowitz, RE Settlage, ... The Journal of Immunology 164 (12), 6120-6129, 2000 | 96 | 2000 |
| Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer Clinical Cancer Research 25 (17), 5315-5328, 2019 | 91 | 2019 |
| A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells GS Taylor, HM Long, TA Haigh, M Larsen, J Brooks, AB Rickinson The Journal of Immunology 177 (6), 3746-3756, 2006 | 87 | 2006 |
| Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis H Mehanna, M Taberna, C Von Buchwald, S Tous, J Brooks, M Mena, ... The Lancet Oncology 24 (3), 239-251, 2023 | 82 | 2023 |
| Characterization of two Epstein‐Barr virus epitopes restricted by HLA‐B7 A Hill, A Worth, T Elliott, S Rowland‐Jones, J Brooks, A Rickinson, ... European journal of immunology 25 (1), 18-24, 1995 | 81 | 1995 |
| Genetic modulation of antigen presentation by HLA-B27 molecules. L Pazmany, S Rowland-Jones, S Huet, A Hill, J Sutton, R Murray, ... The Journal of experimental medicine 175 (2), 361-369, 1992 | 72 | 1992 |
| Early T cell recognition of B cells following Epstein-Barr virus infection: identifying potential targets for prophylactic vaccination JM Brooks, HM Long, RJ Tierney, C Shannon-Lowe, AM Leese, ... PLoS pathogens 12 (4), e1005549, 2016 | 55 | 2016 |
| Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains JM Brooks, DSG Croom-Carter, AM Leese, RJ Tierney, G Habeshaw, ... Journal of virology 74 (4), 1801-1809, 2000 | 54 | 2000 |
| A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds M Dryden, A Dickinson, J Brooks, L Hudgell, K Saeed, KF Cutting journal of wound care 25 (3), 140-146, 2016 | 43 | 2016 |
